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Abstract
Purpose: Graft failure remains an obstacle to experimental subretinal cell transplantation. A key step is preparing a viable
graft, as high levels of necrosis and apoptosis increase the risk of graft failure. Retinal grafts are commonly harvested from
cell cultures. We termed the graft preparation procedure ‘‘transplant conditions’’ (TC). We hypothesized that culture
conditions influenced graft viability, and investigated whether viability decreased following TC using a mouse retinal
pigment epithelial (RPE) cell line, DH01.
Methods: Cell viability was assessed by trypan blue exclusion. Levels of apoptosis and necrosis in vitro were determined by
flow cytometry for annexin V and propidium iodide and Western blot analysis for the pro- and cleaved forms of caspases 3
and 7. Graft viability in vivo was established by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and
cleaved caspase 3 immunolabeling of subretinal allografts.
Results: Pre-confluent cultures had significantly less nonviable cells than post-confluent cultures (6.6%60.8% vs.
13.1%60.9%, p,0.01). Cell viability in either group was not altered significantly following TC. Caspases 3 and 7 were not
altered by levels of confluence or following TC. Pre-confluent cultures had low levels of apoptosis/necrosis (5.6%61.1%)
that did not increase following TC (4.8%60.5%). However, culturing beyond confluence led to progressively increasing
levels of apoptosis and necrosis (up to 16.5%60.9%). Allografts prepared from post-confluent cultures had significantly
more TUNEL-positive cells 3 hours post-operatively than grafts of pre-confluent cells (12.7%63.1% vs. 4.5%61.4%,
p,0.001). Subretinal grafts of post-confluent cells also had significantly higher rates of cleaved caspase 3 than pre-confluent
grafts (20.2%64.3% vs. 7.8%61.8%, p,0.001).
Conclusion: Pre-confluent cells should be used to maximize graft cell viability.
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Introduction
Retinal cell transplantation has been proposed as a therapeutic
option for non-neovascular retinal degenerations[1]. This aims to
replace atrophic or dysfunctional retina or retinal pigment epithelium
(RPE) with healthy donor cells, including primary cell cultures,
immortalized cell linesa n ds t e mc e l l s .R P Eg r a f t si nt h eR o y a lC o l l e g e
of Surgeons rat model of retinal degeneration have been shown to
prevent overlying photoreceptor degeneration[2] and delay deterio-
ration in visual function[3,4]. Mouse rod photoreceptor precursor cell
grafts can integrate into the host retina and contribute to visual
function in both wild-type and degenerate retinae[5]. However, these
studies found the benefit to be short-term due to graft loss. Human
embryonic stem cell-derived RPE grafts have been shown to rescue
visual function in rat and mouse models of retinal degeneration[6].
Although some long-term functional rescue was evident in this study,
the rescue steadily decreased with time post-transplantation.
Different mechanisms at each stage of the transplantation
procedure may influence graft survival including sub-optimal
culture conditions. Subretinal grafts are commonly harvested from
cell cultures and transplanted as highly concentrated cell suspen-
sions. In the early post-operative period, graft loss may occur
through apoptosis, a particular concern for RPE cell replacement
strategies (primary[7], extended life[3,8–14], or stem cell-de-
rived[6]) as these are anchorage-dependent cells and undergo
anoikis when dissociated from their basement membrane[15].
Furthermore, grafts are prone to detection by the innate immune
system and subsequent attack by the adaptive immune system.
Ultimately, transplanted cells that have survived these hazards must
also integrate into the host tissue and function as a replacement for
the degenerateordysfunctional host cells. RPE graftsmustintegrate
onto Bruch’s membrane and develop apical-basolateral polarity to
function[16]. Thus, it is crucial for the transplant to be optimized in
terms of preparation, delivery, survival and function.
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preparation using the mouse subretinal RPE allograft model. This
involves optimizing RPE culture conditions at the crucial stage
between harvesting the graft and delivering it to the graft site. Two
potential mechanisms of cell death in the prepared graft are
apoptosis and necrosis. Apoptosis is a process of programmed cell
death and may be initiated from within a cell (intrinsic pathway) or
from extracellular ligands (extrinsic pathway). Caspases are
proteases of the apoptotic cascade and converge on effector
caspases such as caspase-3 and -7, which execute cell death[17,18].
Membrane disruption such as phosphatidylserine externalization
also occurs during apoptosis[19] and can be identified by annexin
V binding[20]. Phagocytes detect and clear apoptotic cells via the
presence of this phospholipid[21,22]. Necrotic cells are liable to
initiate and propagate an inflammatory response via the release of
damage-associated molecular patterns (DAMPs)[23–25] and high
mobility group box 1 (HMGB1)[26–29], which will adversely
affect graft survival via activation of the innate immune system.
This study aimed to (a) optimize graft cell preparation by
defining the culture conditions which would result in a graft of
high viability, and (b) to establish whether the stress of preparing
the graft cell suspension adversely affected graft cell viability in
vitro and in vivo. Both of these aims were achieved in this study.
The data presented here demonstrates that pre-confluent cells
should be used to maximize graft cell viability and that the graft
preparation procedure used does not adversely affect viability.
Methods
Ethics statement
This study was performed in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. Ethical approval for this research was obtained from
University College Dublin animal research ethics committee
(AREC-P-07-09-Keegan). All surgery was performed under
ketamine and medetomidine anaesthesia, and all efforts were
made to minimize suffering. C57BL/6 mice were obtained from
Harlan UK (Bicester, UK).
Cell line derivation
The DH01 RPE line was prepared from RPE cultured from a
healthy C57BL/10.RIII-H-2
r mouse and immortalized using
supernatant from the SVU 19.5 cell line[30] secreting retrovirus
encoding a temperature-sensitive non-SV40 origin-binding U19
mutant of the SV40 large T antigen (SV40T) and the neomycin
resistance gene[31]. Cells were selected in medium containing
0.5 mg/ml Geneticin (G418 Life Technologies, Paisley, UK) for
1–2 weeks. Cells were cloned by limiting dilution in a 96 well plate
with progressive 1:10 dilutions, which were then plated in wells
with 250 ml medium and observed daily. When one single cell was
present in a well, this was highlighted and allowed to divide. When
this culture reached confluence, it was trypsinised and put in a
flask to expand up. Cells were shown to express SV40T by
immunocytochemistry on 4% formaldehyde-fixed, 0.2% Triton-
X-permeabilized cells using a SV40T-specific monoclonal anti-
body (gift from Dr. P. Jat, Ludwig Institute, London, U.K).
Cell culture
DH01 cells were routinely cultured in high glucose Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma-Aldrich Ireland,
Wicklow, Ireland) supplemented with 1% fetal calf serum (Sigma,
Ireland) 200 mM L-glutamine (Sigma, Ireland) and 5 mg/ml
penicillin/streptomycin (Sigma, Ireland). As these cells harbour
SV40T they were grown at 33uCi n5 %C O 2.
Appearance of DH01 cells in culture and cell growth
assay
DH01 cells were seeded in T75 tissue culture flasks at increasing
cell numbers (0.5610
6 to 20610
6) and cultured for 7 days in full
medium. Confluence was defined as the absence of spaces between
cells in culture when viewed under phase contrast microscopy.
The appearance and status of confluence on Day 7 was captured
under phase contrast microscopy using a Nikon TS100 inverted
microscope and a Nikon Coolpix 995 digital camera. Cells were
counted in triplicate using a haemocytometer. Results are
representative of 3 independent experiments.
Transplant conditions (TC) and baseline conditions (BC)
To determine if the process of preparing a graft cell suspension
adversely affected viability, we examined DH01 cells immediately
following resuspension in full media (Baseline Conditions, BC) and
after being prepared for subretinal transplantation (Transplant
Conditions, TC). TC cells were prepared as a highly concentrated
cell suspension (50,000 cells/ml), deprived of serum (suspended in
serum-free medium), and kept on ice for the maximum period that
typically exists between harvesting and transplanting the graft
(4 hours).
Cell viability assay (trypan blue exclusion)
To determine if either confluence or TC affected DH01 cell
viability, T75 tissue culture flasks were seeded with 0.5610
6 cells/
flask (to yield pre-confluent cultures) and 20610
6 cells/flask (to
yield post-confluent cultures) and cultured for 7 days in full
medium. Cell viability was assessed under both BC and TC by
counting the percentage of cells that excluded trypan blue. Results
represent 3 independent experiments and are presented as
mean6standard deviation (SD).
SDS-polyacrylamide gel electrophoresis
T75 flasks were seeded with 0.5610
6 cells/flask (to yield pre-
confluent cultures) and 20610
6 cells/flask (to yield post-confluent
cultures) and cultured for 7 days in full medium. Western blotting
was then performed as previously described[32]. 30 mg of total
protein was electrophoresed on 12% polyacrylamide gels followed
by transfer to nitrocellulose membrane (Schleicher and Schuell,
Dassel, Germany) and incubated overnight at 4uC with the
antibodies for caspase 3 (Cell Signaling 9662) and caspase 7 (Cell
Signaling 9492). An antibody for b-actin (Cell Signaling 4967) was
used to confirm equal protein loading between samples.
Membrane development was achieved by enhanced chemilumi-
nescence (Amersham, Buckinghamshire, UK). Results are repre-
sentative of 3 independent experiments.
Flow cytometry
DH01 cells were cultured to increasing levels of confluence as
described in cell growth assay above and examined either under
BC or following TC. Cell viability (10
6 cells per assay) was assessed
using a TACSH annexin V (AnV) fluorescein isothiocyanate
(FITC) kit (Catalog# 4830-01-K) with propidium iodide (PI)
counterstaining following the manufacturer’s protocol. Samples
were processed by flow cytometry within one hour on a Beckman
Coulter CyAn ADP flow cytometer and analysed using FlowJo
software. Cells re-suspended in binding buffer alone, and cells
stained with AnV only, or PI only, were used to calibrate the
machine, control for compensation, and establish regions and
gates. Samples were gated to exclude debris, and 20,000 cells were
analysed per sample. Results are representative of 4 independent
experiments and are presented as mean6SD.
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DH01 cell suspensions (50,000 cells/ml DMEM) were prepared
from both pre-confluent and post-confluent cultures as described
under Transplant Conditions above. Subretinal transplants were
delivered via trans-scleral injection through a glass micropipette to
6 eyes of 6 different C57BL/6 mice. Eyes received either 2 mlo f
the pre-confluent graft cell suspension (n=3) or the post-confluent
graft cell suspension (n=3). The animals were euthanized 3 hours
post-operatively, the eyes removed and fixed in 4% paraformal-
dehyde. This early time point was chosen to minimize the risk of
post-operative graft cell death due to factors such as anoikis and
the host immune response influencing the result observed. The
tissue was then cryoprotected in sucrose, embedded in OCT under
liquid nitrogen, and stored at 280uC. 7 mm sections were cut on a
Leica cryostat and stained as described below.
Graft Identification (SV40T), Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) and cleaved
caspase 3 immunolabaling of subretinal RPE transplants
Cryosections were stained with 49,6-diamidino-2-phenylindole
(DAPI) to label all nuclei. Graft cells were identified using a
specific primary antibody to SV40T (Santa Cruz, SC-20800) and
anti-rabbit Texas Red-labeled secondary antibody (Jackson, 111-
075-003). Sections were also stained to detect either DNA strand
breaks or cleavage of caspase 3. DNA strand breaks were detected
by TUNEL as previously described[32]. Cleaved caspase 3 was
immunolabeled with a specific primary antibody conjugated to
Alexa Fluor 488 (Cell Signaling, #9669S). Sections were mounted
using Vectashield hardset (Vector laboratories). Immunostaining
was visualized using an Olympus FV1000 confocal microscope. Z-
stack images through 3 sections per eye were taken with the
microscope settings kept constant for voltage, gain, and offset
throughout the series of imaging. Differential interference contrast
microscopy (DIC) images were taken at the time of fluorescent
confocal microscopy to more accurately identify the subretinal
space. The percentage of graft cells (DAPI
+/SV40T
+) in the
subretinal space that were TUNEL-positive or cleaved caspase 3-
positive was calculated and averaged across 3 sections per eye. The
results presented are mean6SD.
Statistical analysis
Data are given as mean6SD. For the in vitro portion of the study,
a Student’s t-test assuming unequal variances was used for
comparisons between groups to determine whether there was a
s i g n i f i c a n td i f f e r e n c eb e t w e e nt h et w os a m p l em e a n s .D u et ot h e
smaller sample sizes for the in vivo analysis, differences in proportions
between pre-confluent cell transplants versus post-confluent cell
transplants were established by Pearson’s Chi-Square test. *Signifi-
cant at p,0 . 0 5 ;* * S i g n i f i c a n ta tp ,0.01; ***Significant at p,0.001.
Results
DH01 RPE cells are not contact inhibited in culture
To determine the cell growth characteristics of DH01 cells, T75
flasks were seeded (Day 0) with increasing numbers of cells
(0.5610
6 to 20610
6 cells/flask) and cultured for 7 days. The
corresponding appearance of cultures on Day 7 showed increasing
cell density under phase contrast microscopy (Figure 1a) and an
Figure 1. Analysis of cell growth rates demonstrates that DH01 cells are not contact-inhibited. DH01 RPE cells were seeded (Day 0) at
increasing cell numbers. Phase contrast images and cell counts were performed on Day 7. (A) Phase contrast microscopy of the corresponding
appearance on Day 7 of cells seeded on Day 0 (0.5610
6 to 20610
6) showing increasing cell density. Scale bar equals 50 mm. (B). Cell counts on Day 7
of T75 flasks seeded with increasing cell numbers on Day 0. Dotted line approximates cell numbers at confluence. Results are representative of 3
independent experiments.
doi:10.1371/journal.pone.0021365.g001
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(Figure 1b). Flasks seeded with 0.5610
6 and 1610
6 cells were
pre-confluent at Day 7. Flasks seeded with 5610
6 cells were
confluent on Day 7 with 30.9610
663.5610
6 cells. However,
DH01 cells were not contact inhibited as higher seeding levels
resulted in cell numbers on Day 7 higher than those seen at
confluence. 10610




6 cells seeded resulted in 49.2610
663.9610
6
cells on Day 7. T75 flasks seeded with 10610
6 or 20610
6 cells
were deemed to result in post-confluent cultures.
Graft cell viability is reduced by culturing DH01 cells
post-confluence, but is unaffected by transplant
conditions
We sought to ascertain if culturing DH01 cells post-confluence or
the process of preparing cells for transplantation (TC) induced cell
death, and more specifically apoptosis. We cultured DH01 cells to
pre-confluent (0.5610
6 cells seeded) and post-confluent levels (20
x10
6 cells seeded) and examined on Day 7 for viability (trypan blue
exclusion) and caspase activation under BC and TC. Pre- confluent
cultures had only background levels of cell death present (0.5 BC:
6.6%60.8%) that didnot increase significantly (p=0.799) following
TC (0.5 TC: 6.7%61.1%) (Fig. 2a). Levels of cell death in post-
confluent cultures increased significantly (p=0.003) under BC (20
BC:13.1%60.9%)comparedtopre-confluentcells.However,there
was no further increase in cell death following TC (20 TC:
13.4%60.8%). We then investigated the possible activation of
apoptotic pathways by examining the expression of caspases 3 and
7. Figure 2b shows that no difference was detectible in expression of
either caspase following TC or in post-confluent cultures. It should
also be noted that the antibodies used are for the detection of both
the pro- and cleaved forms of caspases 3 and 7, however the
cleavage products were not detected.





7 days yielding pre- and post-confluent cultures (as per Fig. 1b) and
then examined under BC or TC. We measured cell death by
double-labeling cells with FITC-conjugated AnV and PI (Fig. 3a).
Disorganization of the plasma membrane occurs early in apoptosis
and is characterized by phosphatidylserine flipping from the inner
to the outer leaflet of the plasma membrane. In the presence of
Ca
2+, annexin V binds phosphatidylserine with high affinity,
allowing the detection of the apoptotic population by flow
cytometry. To differentiate early apoptotic from late apoptotic
cells, cells were also stained with PI, a fluorescent indicator of
plasma membrane integrity. Annexin V-positive but PI-negative
events represent cells in the early stages of apoptosis, whereas events
positive for both markers correspond to cells in late apoptosis, when
plasma membrane permeability has been compromized. PI-positive
butAnV-negativeeventsrepresent deadcellsdistinctfrom apoptosis
and were designated necrotic. Analysis (Fig. 3) showed that pre-
confluent cells (0.5610
6 cells seeded) examined under BC (0.5 BC)
had low levels of cell death (0.5 BC: 5.6%61.1%) that did not
increase significantly following TC (0.5 TC: 4.8%60.5%)
(p=0.218). This population included low levels of both apoptotic
and necrotic cells. Flasks seeded at higher levels (1610
6 cells), but
still pre-confluent on day 7, had similarly low levels of cell death (1
TC: 5.1%60.5%). However, flasks seeded with 5610
6 cells were
confluent on day 7 and had significantly higher (p,0.001) levels of
cell death following TC (5 TC: 9.0%60.8%). Cells cultured to post-
confluence showed a progressive increase in overall levels of cell
death with the maximum levels seen in cultures seeded with20610
6
cells (20 TC: 16.5%60.9%). This population was predominantly
accounted for by necrotic cells (AnV
-/PI
+: 9.0%61.2%) and cells in
the late stages of apoptosis (AnV
+/PI
+: 5.8%61.0%). A summary of
these results is displayed in Table 1.
Transplanting pre-confluent cells increases graft cell
viability in an in vivo model
Pre-confluent and post-confluent DH01 cells were prepared
under TC and transplanted to the subretinal space of allogeneic
mice (n=3 eyes in each group). Eyes were removed 3 hours post-
Figure 2. Preparation of DH01 cells under transplant condi-
tions does not induce cell death. (A) When 20610
6 cells (20) were
seeded they exhibited significantly (p,0.01) higher levels of nonviable
cells than flasks seeded with 0.5610
6 cells (0.5) as measured by trypan
blue exclusion, however, transplant conditions (TC) did not significantly
affect viability compared to baseline conditions (BC) (p=0.799). Data
are given as mean6SD and are representative of 3 independent
experiments. (B) SDS-PAGE analysis of caspase 3 and 7 expression in
cells seeded at varying cell densities (0.5610
6 cells and 20610
6) and
prepared under baseline and transplant conditions using antibodies
sensitive for the pro- and cleaved forms. There was no change in the
expression of either caspase 3 or 7 (pro-form) and we did not detect the
cleaved fragments. Actin is used as a loading control and results are
representative of 3 independent experiments. NS=not significant.
**Significant at p,0.01.
doi:10.1371/journal.pone.0021365.g002
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PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e21365Figure 3. Culture of DH01 cells to post-confluence prior to transplantation induces apoptosis and necrosis. (A) Representative flow
cytometry dot plots for annexin V (AnV) and propidium iodide (PI) showing that transplant conditions (TC) did not affect cell viability compared to
baseline conditions (BC). However, overall levels of late apoptosis (AnV
+,P I
+) and necrosis (AnV
-,P I
+) increased in cell suspensions prepared post-
confluence. (B) Graphical representation of the levels of nonviable cells presented as early apoptotic (AnV
+/PI





+, black). Error bars reflect standard deviation of the total (0.5–20 represent numbers of cells seeded x10
6 on Day 0; BC=baseline
conditions; TC=transplant conditions; NS=not significant; *Significant at p,0.05; ***Significant at p,0.001).
doi:10.1371/journal.pone.0021365.g003
Table 1. Summary of rates of cell death examined under increasing levels of cell confluence (0.5 to 20) and under baseline
conditions (BC) or transplant conditions (TC).














0.5 BC 2.660.2 1.760.5 1.360.8 5.661.1
0.5 TC 1.260.1 2.360.2 1.360.7 4.860.5
1T C 0.860.1 3.060.6 1.360.3 5.160.5
5T C 0.260.1 3.860.5 5.061.0 9.060.8
10 TC 0.960.3 8.060.7 6.362.2 15.262.4
20 TC 1.860.5 5.561.0 9.061.2 16.560.9
Flow cytometric analysis of cell suspensions prepared from increasingly confluent cultures examined either immediately following resuspension (baseline conditions,
BC) or after undergoing the transplant preparation procedure (transplant conditions, TC). Flasks seeded with 0.5610
6 (0.5) and 1610
6 (1) cells were pre-confluent at Day
7. Flasks seeded with 5610
6 cells (5) were confluent on Day 7. Flasks seeded with 10610
6 cells (10) and 20610
6 cells (20) resulted in increasingly post-confluent cultures.
Cells were stained with annexin V (AnV) and propidium iodide (PI). The data demonstrates that cells from pre-confluent cultures have low levels of total cell death (0.5
BC: 5.6%61.1%) and that this does not increase following TC (0.5 TC: 4.8%60.5%). However, cells from post-confluent cultures have progressively increasing levels of
cell death (up to 20 TC: 16.5%60.9%).
doi:10.1371/journal.pone.0021365.t001
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SV40T immunolabeling.Apoptotic and necrotic cells were detected
byTUNEL-labeling,amethodfordetectingDNAfragmentationby
labeling the terminal end of nucleic acids. Subretinal allografts of
DH01 cells prepared from pre-confluent cultures had lower levels of
TUNEL-positive cells compared to grafts of post-confluent cells
(Fig. 4a). Three sections from each graft were imaged and the
average percentage of TUNEL-positive graft cells in the subretinal
space calculated. This demonstrated a significant increase
(p,0.001) in the percentage of TUNEL-positive cells following
transplantation of post-confluent cells (12.8%63.1%) compared to
pre-confluent cells (4.5%61.4%) (Fig 4b). To validate this result,
three sections per eye were also immunolabeled for cleaved caspase
3 (Fig. 5a) and analyzed as per the TUNEL staining described
above. This confirmed significantly greater (p,0.001) levels of
caspase 3 cleavage in post-confluent grafts (20.2%64.3%) com-
pared to pre-confluent grafts (7.8%61.8%) (Fig. 5b).
Discussion
Subretinal cell transplants are commonly harvested from cell
cultures and delivered as high concentration cell suspensions. In vitro
and in vivo these cells are exposed to local conditions that are likely to
influence cell growth and performance. Primary cell lines are
troublesome due to limited access, complex harvesting techniques,
and unstable phenotype after few passages in culture. Transformed
cell lines are therefore an attractive option for ease of access and
reproducibility of genotype and phenotype within and between
laboratories. This study used the mouse RPE cell line, DH01, to
optimize graft preparation and survival. We found that DH01 is not
contact inhibited in culture as cell numbers continued to increase
even after cultures reached confluence. Pre-confluent DH01 cells in
suspension had 6.6% nonviable cells, but this approximately doubled
to 13.1% using post-confluent cultures. Although it appears optimal
to culture high numbers of cells to ensure an adequate graft is
available for transplantation, our findings refute this approach.
Although more cells will be available in post-confluent cultures, we
have shown that a higher proportion of these will be nonviable.
Adverse effects of the graft preparation procedures on cell
viability should be minimized. One important difference between
cell transplants and solid tissue or organ transplants is that cell
transplants are often derived from cell cultures and delivered as a
cell suspension (stem cells[33], Schwann cells[34,35], pancreatic
islet cells[36] and RPE cells[2-4]). We found that pre-confluent
cultures had significantly lower levels of nonviable cells than post-
confluent cultures. However, the graft preparation procedure (TC)
did not adversely affect viability in grafts prepared from pre-
confluent or from post-confluent cultures (Figs. 2a and 3, Table 1).
We investigated whether cell death in post-confluent cultures
was due to apoptosis but consistently found no difference in
Figure 4. Pre-confluent grafts have greater viability in vivo. (A) DH01 allografts 3 hours post-transplant. Graft cells are identified via
immunolabeling SV40T (Texas red) and apoptotic/necrotic cells via TUNEL-labeling (FITC, green). All nuclei are stained with DAPI (blue). The subretinal
location of the graft cells is highlighted in the DIC images. Levels of cell death were lower in grafts of pre-confluent cells (left) than post-confluent
cells (right). Scale bar 50 mm. (B) There is a significant increase in levels of cell death in grafts of post-confluent cells compared to grafts prepared
from pre-confluent cultures. ***Significant at p,0.001.
doi:10.1371/journal.pone.0021365.g004
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and post-confluent cultures (TC) (Fig. 2b). We did find that levels
of early apoptosis remained low (1–2%) in pre- and post-confluent
cultures, but the proportion of cells in the late stages of apoptosis
increased from just 2% in pre-confluent cultures to between 6%
and 8% in post-confluent cultures. However, the biggest change in
cell death was due to necrosis, increasing from 1% in pre-confluent
cultures to 9% in post-confluent cultures. The predominance of
necrosis over apoptosis in graft cell loss has been previously
observed in Schwann cell transplantation to the spinal cord where
six times more cells died by necrosis than by apoptosis during the
first week after transplantation[34]. We also confirmed that pre-
confluent cultures were 95% viable and this did not decrease
following the graft preparation procedure (Figs. 2 and 3).
Finally, we wanted to confirm that pre-confluent cultures
resulted in greater graft viability than post-confluent cultures in
vivo. To achieve this, we employed a mouse model of subretinal
transplantation and examined subretinal grafts for cell death three
hours post-operatively by TUNEL-labeling. This early post-
operative time-point was chosen in order to minimize the risk of
post-operative graft cell death due to factors such as anoikis and
the host immune response influencing the result observed in this
study which aimed to optimize graft preparation. DNA fragmen-
tation is not exclusive to apoptosis. Necrosis can also be
accompanied by DNA breaks and thus TUNEL-labeling also
detects necrotic cells[37-39]. The DH01 cell line is immortalized
using the nuclear protein SV40T. Therefore, we were able to use
this marker in conjunction with TUNEL-labeling to determine the
rates of apoptosis/necrosis in our subretinal transplants. We found
that grafts from pre-confluent cultures had a lower proportion of
TUNEL-positive cells than grafts from post-confluent cultures
(Fig. 4a). This difference is consistent across a series of transplants
(Fig. 4b) and closely mirrors our in vitro data (Figs. 2a and 3b).
Caspase 3 is a key executioner of apoptosis and is activated when
cleaved by upstream signals[40]. To validate the data seen with
TUNEL-labeling, sections were also immunolabeled for cleaved
caspase 3. This confirmed greater rates of caspase 3 cleavage in
post-confluent grafts compared to pre-confluent grafts. Rates of
caspase 3 cleavage were higher than rates of TUNEL-labeling.
This may be due to the identification of cells in earlier stages of
apoptosis that have not yet developed DNA fragmentation
demonstrable by TUNEL-labeling. Another method that could
be considered to compare graft viability in vivo between the two
groups is PI co-administration with the graft cell suspen-
sion[41,42]. Thus, the in vivo data was consistent with the in
vitro data and found that using pre-confluent cells resulted in
significantly lower levels of graft apoptosis/necrosis in the
subretinal space three hours post-operatively.
Figure 5. Pre-confluent grafts have less apoptosis in vivo. (A) DH01 allografts 3 hours post-transplant. Graft cells are identified via
immunolabeling SV40T (Texas red) and apoptotic cells via cleaved caspase 3 (CC3) immunolabeling (Alexa Fluor 488, green). All nuclei are stained
with DAPI (blue). The subretinal location of the graft cells is highlighted in the DIC images. Rates of cleaved caspase 3 were lower in grafts of pre-
confluent cells (left) than post-confluent cells (right). Scale bar 50 mm. (B) There is a significant increase in rates of apoptosis in grafts of post-
confluent cells compared to grafts prepared from pre-confluent cultures. ***Significant at p,0.001.
doi:10.1371/journal.pone.0021365.g005
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graft rejection as well as graft performance. Necrosis is an
inherently more inflammatory process than apoptosis and causes
an inflammatory response via the release of molecules such as
DAMPs[23–25] and HMGB1[26], which can stimulate mono-
cytes and macrophages[25,27–29,43], enhance dendritic cell
maturation[44–46], and promote natural killer cell chemotaxis
and cytolytic activity[47]. Phagocytes can also detect and clear
apoptotic cells via the presence of externalized phosphatidylser-
ine[21,22]. Although apoptotic cells do not release their
HMGB1[26], when engulfed by macrophages apoptotic cells
actually induce the phagocytes to release HMGB1[48]. Thus,
although low grade apoptosis does not induce inflammation,
extensive apoptosis is capable of inducing an inflammatory
response[49]. High levels of apoptosis and necrosis in the graft
are therefore likely to activate local innate inflammatory immune
responses, some of which may target the graft.
Graft necrosis and apoptosis, together with activated local
inflammation, also increase the risk of an allogeneic adaptive
immune response. Necrotic debris can be engulfed by phagocytes
which may act as antigen-presenting cells and trigger an adaptive
immune response against the graft[50]. Extensive apoptosis can
trigger dendritic cell maturation, antigen-presentation and an
adaptive immune response[51–53]. Consequently the remaining
cells within the transplant, although neither apoptotic nor necrotic,
could be presenting specific antigens to clonally expanding T- and
B-cells primed to attack these allogeneic cells. Therefore it is
critical to minimize apoptosis and necrosis in the graft in order to
minimize the risk of graft failure.
It follows therefore that the benefits of minimizing apoptosis and
necrosis within a graft are threefold: apoptosis and necrosis are
themselves inherent mechanisms of graft cell loss and graft failure;
these nonviable cells are likely to trigger a local inflammatory
innate immune response at the graft site; and finally, perhaps most
significantly, the more of these dead cells that are cleared by
phagocytes, the higher the risk of consequent targeted graft attack
by the adaptive immune system. These issues are now the subject
of further in vivo studies and investigation.
Transplantation of cell suspensions to the subretinal space is
now being superseded by the transplantation of patches, i.e. of cells
on the platform on which they were cultured. There are several
good reasons for this. For example, graft cell suspensions when
transplanted to the subretinal space have an unpredictable
distribution due to the fluid nature of the graft. In contrast,
transplantation of a sheet of graft cells cultured on a platform
offers the possibility of controlling graft size and position. For RPE
grafts in particular, anoikis[15], is a potential source of graft failure
in RPE cell suspension transplantation that may be overcome by
transplantation on a platform. A crucial function of RPE cells is
maintenance of the outer blood-retinal barrier. To achieve this, it
is vital that these cells are confluent and create tight junctions to
prevent the free passage of water and large molecules from the
choriocapillaris to the subretinal space. For this reason it will be
desirable in the future to culture RPE cells to confluence on a
platform prior to transplantation. However, our findings demon-
strate that care must also be taken not to culture the cells beyond
confluence due to rising levels of apoptosis and necrosis and the
problems this may provoke in terms of initiating an inflammatory
or immune response against the graft.
There is currently no permanent treatment for retinal
degenerations. However transplantation offers an attractive
possibility. The success of this approach will require optimum
graft survival and function; however no previous work has
described best practice for graft cell preparation as illustrated in
this paper. Our future work will examine the use of patch
transplants to enhance graft survival and on modification of the
innate immune response. The future success of subretinal
transplantation will be determined by the ability to prepare grafts
to a reproducibly high standard, with maximum graft viability and
function, in conjunction with minimum inflammatory and
immune reactions.
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